Steven Collis - AmerisourceBergen Pres Chairman

ABG Stock  EUR 232.05  0.25  0.11%   

Insider

Steven Collis is Pres Chairman of AmerisourceBergen
Age 62
Phone610 727 7000
Webhttps://www.amerisourcebergen.com

Steven Collis Latest Insider Activity

Tracking and analyzing the buying and selling activities of Steven Collis against AmerisourceBergen stock is an integral part of due diligence when investing in AmerisourceBergen. Steven Collis insider activity provides valuable insight into whether AmerisourceBergen is net buyers or sellers over its current business cycle. Note, AmerisourceBergen insiders must abide by specific rules, including filing SEC forms every time they buy or sell AmerisourceBergen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

AmerisourceBergen Management Efficiency

The company has return on total asset (ROA) of 0.0294 % which means that it generated a profit of $0.0294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.502 %, meaning that it generated $0.502 on every $100 dollars invested by stockholders. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.
AmerisourceBergen has accumulated 4.63 B in total debt with debt to equity ratio (D/E) of 152.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AmerisourceBergen has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AmerisourceBergen until it has trouble settling it off, either with new capital or with free cash flow. So, AmerisourceBergen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AmerisourceBergen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AmerisourceBergen to invest in growth at high rates of return. When we think about AmerisourceBergen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Wenjian WangSunny Optical Technology
76
Anja JasperSMA Solar Technology
N/A
Marko WernerSMA Solar Technology
60
Volker WachenfeldSMA Solar Technology
N/A
Wenjie WangSunny Optical Technology
56
Jeanete KlokgetherSMA Solar Technology
N/A
Guojun LouSunny Optical Technology
58
Julia DammSMA Solar Technology
N/A
Yanfeng LiuSunny Optical Technology
N/A
Volker WasgindtSMA Solar Technology
N/A
Yunfeng SongSunny Optical Technology
58
Jurgen ReinertSMA Solar Technology
55
Jianfeng MaSunny Optical Technology
50
Barbara GregorSMA Solar Technology
53
Yang SunSunny Optical Technology
50
Liaoning YeSunny Optical Technology
57
Pui WongSunny Optical Technology
41
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania. AMERISOURCEBERGEN operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21000 people. AmerisourceBergen (ABG) is traded on Frankfurt Exchange in Germany and employs 39,000 people.

Management Performance

AmerisourceBergen Leadership Team

Elected by the shareholders, the AmerisourceBergen's board of directors comprises two types of representatives: AmerisourceBergen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AmerisourceBergen. The board's role is to monitor AmerisourceBergen's management team and ensure that shareholders' interests are well served. AmerisourceBergen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AmerisourceBergen's outside directors are responsible for providing unbiased perspectives on the board's policies.
PharmD Mauch, Ex COO
Steven Collis, Pres Chairman
Kathy Gaddes, Ex Officer
James Cleary, Ex CFO
Elizabeth Campbell, Ex Officer
Bennett Murphy, VP Relations
Silvana Battaglia, Ex Officer
Lazarus Krikorian, Chief VP
John Chou, Ex CEO
Gina Clark, Exec Officer

AmerisourceBergen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AmerisourceBergen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in AmerisourceBergen Stock

AmerisourceBergen financial ratios help investors to determine whether AmerisourceBergen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AmerisourceBergen with respect to the benefits of owning AmerisourceBergen security.